| Literature DB >> 23057645 |
Irene Neuner1, Jorge Arrubla, Corinna Ehlen, Hildegard Janouschek, Carlos Nordt, Bruno Fimm, Frank Schneider, N Jon Shah, Wolfram Kawohl.
Abstract
BACKGROUND: Tourette syndrome is a neuropsychiatric disorder characterized by motor and phonic tics. Deficient motor inhibition underlying tics is one of the main hypotheses in its pathophysiology. Therefore the question arises whether this supposed deficient motor inhibition affects also voluntary movements. Despite severe motor tics, different personalities who suffer from Tourette perform successfully as neurosurgeon, pilot or professional basketball player.Entities:
Mesh:
Year: 2012 PMID: 23057645 PMCID: PMC3527195 DOI: 10.1186/1471-2377-12-120
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Demographic and clinical data of Tourette patients (n=21)
| 1 | 42 | F | No | No | 46 | 30 | None | Tiapride up to 600mg |
| 2 | 18 | M | Yes | No | 33 | 10 | Sulpiride 100mg | Sulpiride 100mg |
| 3 | 36 | M | No | No | 48 | 20 | None | None |
| 4 | 40 | M | No | No | 49 | 30 | Tiapride 100mg | Tiapride 300mg |
| 5 | 19 | M | N0 | No | 21 | 10 | None | None |
| 6 | 19 | M | No | No | 43 | 20 | None | Pimozide 2mg |
| 7 | 24 | M | No | No | 37 | 10 | None | None |
| 8 | 37 | M | Yes | No | 57 | 30 | Pimozide 4mg Citalopram 20mg | Pimozide 6mg Citalopram 20mg |
| 9 | 21 | M | No | Yes | 56 | 30 | Tiapride 400mg Methylphenidate 60mg | Tiapride 800mg Methylphenidate 60mg |
| 10 | 38 | M | No | No | 37 | 10 | None | None |
| 11 | 25 | F | No | Yes | 43 | 20 | Pimozide 2mg Methylphenidate 40mg | Pimozide 2mg Methylphenidate 40mg |
| 12 | 23 | M | No | No | 24 | 10 | None | None |
| 13 | 22 | F | No | No | 37 | 20 | Trimipramine 50mg | Trimipramine 50mg |
| 14 | 24 | M | No | No | 49 | 20 | None | None |
| 15 | 27 | M | No | No | 47 | 20 | Trimipramine 100mg | Trimipramine 100mg |
| 16 | 27 | M | Yes | No | 55 | 30 | None | None |
| 17 | 28 | F | No | No | 47 | 20 | Pimozide 2mg | Pimozide 2mg |
| 18 | 47 | M | Yes | No | 69 | 30 | None | None |
| 19 | 48 | M | No | No | 37 | 20 | None | None |
| 20 | 48 | M | No | No | 53 | 30 | None | Tiapride 100mg |
| 21 | 35 | M | Yes | No | 48 | 20 | None | Tiapride up to 400mg |
(OCD = comorbid obsessive compulsive disorder, ADHD = comorbid attention deficit hyperactivity disorder, YGTSS = Yale Global Tic Severity Scale).
Figure 1Standardized pegboard of the MLS system. For the subtests steadiness and contour copying the pegboard is presented in an upright position, for the subtests aiming and tapping in a horizontal position. For the subtest steadiness the participants inserted a stick in a hole (5.8 mm diameter, 32 seconds duration, top row, second one from centre) and were required to keep it there without touching by accident the lateral wall or back wall of the hole. The subtest contour copying requires the copying of a given trace without touching the lateral or back walls of the milled out trace (please see Figure 1 third row from top). The subtest aiming requires the volunteer to tap as fast and exact as possible along a line of 20 small circles (diameter 5 mm, distance between circles 4 mm) without touching the pegboard itself (fourth row of the pegboard in Figure 1). The subtest tapping consists of the instruction to tap on a rectangular plate (40mm one side) as fast and often as possible (quadratic area in the sixth row of the pegboard in Figure 1).
Figure 2Boxplots of the Bonferroni-significant t-values (steadiness right, aiming right, steadiness left). Higher t-values indicate better performance.
Fine motor skills in Tourette patients and controls, t-values
| 44.2 ± 8.5 | 53.9 ± 7.8 | ||
| Contacts by error | | | |
| 41.5 ± 7.5 | 45.9 ± 9.2 | .057 | |
| Contacts by error | | | |
| 45.7 ± 14.3 | 59.4 ± 10.4 | ||
| Contacts outside target area | | | |
| 54.8 ± 8.6 | 59.8 ± 10.2 | .127 | |
| Hits in target area | | | |
| 41.2 ± 7 | 50.8 ± 8 | ||
| Contacts by error | | | |
| 49.2 ± 11.3 | 53.9 ± 12.3 | .158 | |
| Contacts by error | | | |
| 50.4 ± 11.3 | 57 ± 12.9 | .051 | |
| Contacts outside target area | | | |
| 56.8 ± 11.4 | 59 ± 13.5 | .351 | |
| Hits in target area |
Higher t-values indicate better performance. (R = right, L = left, *significant difference between Tourette patients and healthy volunteers (pBonf.< 0.00625), pBonf. significant p-values in bold).